Brandon Smith, MD
Emergency Medicine · Bossier City, LANPI 1164633004
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 21 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by AstraZeneca at 39.6% of the total. Reporting peaked in 2024 at $239 and has fallen 52.9% since, to $113 in 2025. Among emergency medicine clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 21 payments — averaging $31.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$259
- Qapel Medical Inc$150
- Stryker$61
- Bard Peripheral Vascular, Inc.$45
- Abiomed$35
- Pfizer$34
- plus $70 from 5 others
What the payments were for
- Food & beverage$655100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 10 | $259 |
| Qapel Medical Inc | 1 | $150 |
| Stryker | 1 | $61 |
| Bard Peripheral Vascular, Inc. | 1 | $45 |
| Abiomed | 1 | $35 |
| Pfizer | 2 | $34 |
| GE HealthCare | 1 | $18 |
| Gilead | 1 | $15 |
| Johnson & Johnson | 1 | $13 |
| BTG International Inc. | 1 | $13 |
| AbbVie | 1 | $12 |
How this compares
$655 in reported general payments places this provider in the 90th percentile of 881 emergency medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 29 | $620 |
| Ondansetron OdtOndansetron | 70 | $470 |
| Ketorolac Tromethamine | 36 | $448 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 81 | $205 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 17 | $199 |
| Ciprofloxacin Hcl | 27 | $140 |
| Prednisone | 66 | $124 |
| Cyclobenzaprine Hcl | 37 | $80 |
| Cephalexin | 15 | $71 |
| Methylprednisolone | 11 | $67 |
| Metronidazole | 13 | $54 |
| Famotidine | 12 | $44 |
| Naproxen | 14 | $36 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Bossier City
- Fred WillisShreveport$427K
- Bryant BoydShreveport$83K
- Thomas ArnoldShreveport$48K
- Noah PoresNew Orleans$34K
- Granville MorseNew Orleans$32K
- Claude DantonioNew Orleans$26K
- Guy LefortCut Off$24K
- Mark DemanuelleDonaldsonville$22K
- Mace ScottBogalusa$17K
- Lisa FortNew Orleans$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.